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P-glycoprotein (P-gp) is a membrane-bound 
efflux pump which actively exports a wide 
range of compounds from the cell and is 
associated with the phenomenon of multidrug-
resistance. However, the role of P-gp in normal 
physiological processes remains elusive. Using 
P-gp deficient fibroblasts, we showed that P-gp 
was critical for the replication of the 
intracellular parasite Toxoplasma gondii, but 
was not involved in invasion of host cells by the 
parasite. Importantly, we found that the protein 
participated in the transport of host-derived 
cholesterol to the intracellular parasite. T. 
gondii replication in P-gp deficient host cells not 
only resulted in reduced cholesterol content in 
the parasite but also altered its sphingolipid 
metabolism. In addition, we found that different 
levels of P-gp expression modified the 
cholesterol metabolism in uninfected 
fibroblasts. Collectively our findings reveal a 
key and previously undocumented role of P-gp 
in host-parasite interaction and suggest a 
physiological role of P-gp in cholesterol 
trafficking in mammalian cells.  
 
P-glycoprotein (P-gp, ABCB1, MDR1) is one of 
the most intensively studied members of the ABC 
transporter superfamily. With remarkably broad 
substrate recognition, P-gp drives the ATP-
dependent efflux of toxic metabolites and 
xenobiotics from the cell (1) and is thus a central 
mediator of drug bioavailability. Importantly, P-gp 
over-expression following drug treatment is 
responsible for the multidrug-resistance (MDR) 
phenotype, a major reason for chemotherapy 
failure not only in cancer cells (2) but also in 
pathogenic microorganisms (3,4). Aside from its 
well known role in drug efflux, P-gp is also 
expressed at basal levels in many different tissues, 
yet the normal physiological functions of the 
protein remain poorly understood. 
The possibility that physiological levels of host P-
gp play a role in host-pathogen interaction, other 
than mediating drug resistance, has not been 
investigated so far. We addressed this question 
using Toxoplasma gondii as a model pathogenic 
parasite. T. gondii is the causative agent of 
toxoplasmosis, a potentially fatal disease not only 
for immunocompromised patients and fetuses but 
according to recent insights also emerging as a life 
threatening  infection in immunocompetent 
individuals (5). T. gondii infects virtually all 
nucleated host cells and resides in a highly 
specialized vacuole, called the parasitophorous 
vacuole (PV), which is formed by invaginating the 
host cell membrane at the time of invasion. The 
PV is not competent for lysosome fusion, thus 
avoiding acidification (6), but it is closely 
associated with host organelles, including 
lysosomes, mitochondria and ER (rev. in (7)). 
Even though the PV does not intersect directly 
with host vesicular traffic, T. gondii remains 
dependent on host cells for a number of critical 
nutrients. Significant progress has been made in 
our understanding of the mechanisms T. gondii 
uses to scavenge nutrients from its host, especially 
in the case of lipid molecules. An important recent 
example was the identification of H.O.S.T., a 
unique system of tubular structures formed by the 
parasite to sequester cholesterol-containing endo-
lysosomes from the host cytoplasm into the PV (8). 
However, the molecular mechanisms of the traffic 
from the host cell to the PV are not completely 
elucidated and the existence of transporters has 
been proposed frequently. 
To analyze whether the P-gp transporter plays a 
role in T. gondii biology we compared parasite 
replication in wild-type (WT) mouse embryonic 
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fibroblasts with double knock out (DKO) 
fibroblasts in which neither of the two murine P-gp 
isoforms are expressed (9). In parallel, we also 
analyzed DKO cells complemented with the 
human P-gp homologue (DKO/P-gp) (10), which 
restored P-gp functionality to DKO cells and 
allowed P-gp expression levels higher than those 
found in WT cells (fig. S1). In this way, our model 
did not depend on either drug-selected P-gp over-
expressing cells, which may acquire adaptation 
mechanisms different from P-gp over-expression 
during the development of the MDR phenotype, or 
P-gp inhibitors, several of which are known to 
have side effects on host metabolism. 
 
EXPERIMENTAL PROCEDURES 
 
Biochemical reagents. Unless otherwise stated, all 
chemicals were purchased from Sigma, cell culture 
reagents from Gibco-BRL, and radiolabeled lipids 
from Amersham Pharmacia Biotech. Anti-P-gp 
monoclonal antibody C219 was purchased from 
Alexis Biochemicals; anti-Lamp1, anti-giantin and 
anti-tubulin were a kind gift from J. Pieters, J. 
Rohrer and M.A. Hakimi, respectively. Conjugated 
secondary antibodies were from Invitrogen. 
Reconstituted high density lipoproteins and 
apolipoprotein A-I were a kind gift from P. Lerch 
(CSL Behring, Bern, Switzerland). NDB-
cholesterol was from Avanti Polar Lipids. 
Mammalian cell and parasite culture. Mouse 
embryonic fibroblasts (MEF) double knocked out 
for P-gp (77.1 , Mdr1a-/-/Mdr1b-/-) (9), triple 
knocked out for P-gp and MRP1 (3.8, Mdr1a-/-
/Mdr1b-/-/Mrp1-/-)  (11) and parental cells were 
kindly provided by A. Schinkel (The Netherlands 
Cancer Institute, Amsterdam, The Nederlands). 
Mdr1 transfected 77.1 (10) and G185 NIH 3T3 
fibroblasts (12) were a generous gift from M.M. 
Gottesman (National Cancer Institute, National 
Institutes of Health, Bethesda, MD).  
Cells were routinely cultured in Dulbecco’s 
modified Eagle medium (DMEM) supplemented 
with 10% fetal calf serum (FCS), 2 mM glutamine, 
50 U of penicillin/mL, and 50 µg of 
streptomycin/mL at 37°C with 5% CO2. Mdr1 
transfected 77.1 and G185 cells were maintained in 
20 and 60 ng/mL colchicine, respectively. 
Colchicine was removed from the culture medium 
during parasite infection. 
β-galactosidase expressing T. gondii and N. 
caninum were a kind gift from J. Boothroyd and D. 
Sibley, respectively. Parasites were maintained by 
serial passages in MEF, harvested from infected 
host cells by passage through a 26-gauge needle 
and purified by separation on Sephadex-G25 
columns (Amersham Biosciences, Otelfingen, 
Switzerland) as described (13). Purified parasites 
were counted in a hemocytometer chamber and 
used for a new cycle of host cell invasion at the 
multiplicity of infection (MOI) of 1. Parasite 
burden was quantified after 24 hrs by direct 
parasite counting or after 48 or 72 hrs by 
colorimetric detection of  parasite β-galactosidase 
using chlorophenol red-β-D-galactopyranoside as 
substrate, as described (14). In some experiments, 
parasite quantification in infected host cells was 
performed by flow cytometry analysis on a 
FACSCalibur flow cytometer (Becton & 
Dickinson, Basel, Switzerland), after staining 
permeabilized cells with a rabbit polyclonal anti-T. 
gondii tachyzoite antiserum (15) at 1:2000 
dilution, followed by fluorescein-conjugated anti-
rabbit secondary antibody at 1:300 dilution.    
Parasite invasion was determined by dual color 
immunostaining with the described anti-T. gondii 
antiserum to differentiate intracellular and 
extracellular parasites, as described (16). 
Lipid analyses. For cholesterol transport to 
intracellular T. gondii, infected host cells were 
labeled with 0.5 µCi/mL [3H]cholesterol for 5 hrs. 
After extensive washing with PBS and 0.05% fat 
free BSA in PBS, parasites were isolated as 
previously described, counted and the associated 
radioactivity measured by liquid scintillation. 
Background radioactivity resulting from host cell 
debris was determined using similarly processed 
uninfected host cells and subtracted from parasite 
samples. 
For cholesterol uptake analysis, host cells were 
incubated with 0.5 µCi/mL [3H]cholesterol for 5 
hrs, extensively washed and cell-associated 
radioactivity measured by liquid scintillation. 
Steady state cholesterol mass was assessed using 
the Amplex Red kit (Invitrogen, Basel, 
Switzerland) or by lipid extraction according to 
(17) and high performance thin layer 
chromatography (HPTLC) separation of aliquots 
corresponding to equal protein content on Silica 
Gel 60 plates in  benzene/2-propanol/water 
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(100:10:0.25). Bands were visualized with 10% 
CuSO4 in 8% aqueous phosphoric acid and 
quantified by densitometry. 
Liquid chromatography-mass spectrometry (LC-
MS) analysis of lipids from T. gondii grown in WT 
or DKO host cells was performed as described (18) 
in a Waters Aquity UPLC system connected to a 
Waters LCT Premier orthogonal accelerated time 
of flight mass spectrometer (Waters, Millford, 
MA), operated in positive electrospray ionization 
mode. 
For analysis of sphingolipid synthesis in T. gondii, 
purified parasites were labeled with 0.5 µCi/mL 
[3H]palmitic acid for 3 hrs, lipids extracted as 
before and aliquots corresponding to equal protein 
content separated by HPTLC using 
chloroform/methanol/25% NH4OH (65:25:4.5). 
Radiolabeled bands were visualized by use of a 
tritium-sensitive screen (Perkin-Elmer, Boston, 
Mass.) in a Personal Molecular PhosphoImager FX 
(Biorad), identified according to co-migrating 
standards visualized by iodine vapors and 
quantified using ImageQuant software (Amersham, 
Otelfingen, Switzerland). 
For kinetic of cholesterol esterification, host cells 
were labeled with 0.5 µCi/mL [3H]cholesterol for 
5, 24 and 48 hrs, lipids were extracted as before 
and separated by HPTLC  using benzene/2-
propanol/water (100:10:0.25) as solvent system. 
After iodine vapors visualization, bands co-
migrating with cholesterol and cholesteryl esters 
standards were cut out of the plates and the 
associated radioactivity measured by liquid 
scintillation. Data for cholesterol esterification are 
reported as percent of [3H]cholesteryl esters from 
total cellular [3H]cholesterol.  
For cholesterol extraction with methyl-β-
cyclodextrin (CD) and efflux to reconstituted high 
density lipoproteins (rHDL) or apolipoprotein A-I 
(apoA-I), cells were labeled with 0.5 µCi/mL 
[3H]cholesterol for 24 hrs, extensively washed and 
incubated with 2 mM CD, 20 µg/mL rHDL or 10 
µg/mL apoA-I in medium without FCS. Medium 
aliquots were measured by liquid scintillation at 
the time points indicated in the figures. Residual 
cell radioactivity was measured after cell 
solubilization in 0.1N NaOH. Total radioactivity 
was calculated as medium + cell associated 
radioactivity. Background efflux to medium alone 
was measured at the same time points and 
subtracted from the values obtained with the 
cholesterol acceptors CD, rHDL and apo-AI. 
Cholesterol visualization and immunofluorescence 
analysis. To visualize intracellular transport of 
fluorescent cholesterol, host cells were seeded on 
glass slides and infected with T. gondii for 24 hrs. 
Cells were incubated with 5 µM NBD-cholesterol 
in DMEM without FCS for 1 hr at 37˚C, fixed in 
3% formaldehyde, mounted in Vectashield 
antifade agent (Vector laboratories, Inc. 
Burlingame, CA) and imaged employing an 
excitation filter of 450–500 nm. 
For visualization of unesterified cholesterol, cells 
were seeded as before, fixed and incubated with 
0.05mg/mL filipin in PBS, 10%FCS for 1 hr at 
room temperature. Images were collected using an 
excitation filter of 350–410 nm. 
For visualization of esterified cholesterol in 
intracellular lipid droplets, cells were fixed with 
3% formaldehyde, blocked and stained with Nile 
red at a concentration of 0.5 µg/mL in PBS for 20 
min. Cells were extensively washed in PBS, 
mounted and lipid fluorescence was analyzed 
employing an excitation filter of 450–500 nm.  
 For P-gp localization, DKO/Pgp host cells grown 
on glass slides were infected with T. gondii for 24 
h, prior fixation in acetone at -20˚C for 10 min. 
Anti-P-gp monoclonal antibody C219 was used at 
1:10 dilution according to the manufacturer 
instruction, followed by fluorescein-conjugated 
secondary antibody at 1: 200 dilution. T. gondii 
was stained with a rabbit polyclonal anti-T. gondii 
tachyzoite antiserum (15) at 1:2000 dilution, 
followed by texas red-conjugated anti-rabbit 
secondary antibody at 1:300 dilution. Nuclei were 
visualized with 4', 6-diamidino-2-phenylindole 
(DAPI). 
For endo-lysosome localization, host cells grown 
on glass slides were infected with T. gondii or N. 
caninum for 24 h, incubated with 6 µg/mL 
fluorescein-conjugated cholera toxin B subunit for 
60 min at 37˚C and analyzed after fixation. 
For lysosome and Golgi localization, cells were 
seeded as before, fixed and stained with anti-
Lamp1 (1:50) or anti-giantin (1:750) antibodies 
followed by fluorescein-conjugated secondary 
antibody. 
Microscopy analyses were performed on a Leica 
DM IRBE fluorescence microscope or on a Leica 
SP2 AOBS confocal laser-scanning microscope 
(Leica Microsystems, Wetzlar, Germany), using 
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the appropriate settings. Image stacks of optical 
sections were further processed using the Huygens 
deconvolution software package version 2.7 
(Scientific Volume Imaging, Hilversum, NL). 
Transmission electron microscopy analysis. Host 
cells grown on sapphire disks were infected with T. 
gondii  and incubated at 37°C for 24 h, prior to 
fixation with 0.25% glutaraldehyde and freezing in 
a high-pressure freezing machine (HPM 010, 
BAL-TEC) as described by (19). Frozen cells were 
transferred into a freeze-substitution unit (FS 7500, 
Boeckeler Instruments, Tucson, Arizona, USA) 
precooled to -88°C for substitution with acetone 
and subsequent fixation with 0.25% glutaraldehyde 
and 0.5% osmium tetraoxide at temperatures 
between -30°C and +2°C as described in detail  
(20) and embedded in Epon. 50 to 60 nm thick 
sections were stained with uranyl-acetate and lead-
citrate and analyzed in a transmission electron 
microscope (CM12, Philips, Eindhoven, The 
Netherlands)  equipped with a CCD camera 
(Ultrascan 1000; Gatan, Pleasanton, CA) at an 
acceleration voltage of 100 kV. 
Cell viability following cholesterol loading. Host 
cells were loaded with cyclodextrin-cholesterol 
complexes (Sigma) for 24 hrs at the concentrations 
indicated in the figure legend, washed in medium 
and incubated at 37˚C for additional 24 hrs. Cell 
viability was tested by using the AlamarBlue® 
assay (Biosource, Camarillo, CA), according to the 
manufacturer instructions. 
P-glycoprotein functional assay. P-gp activity was 
assessed by cellular retention of the P-gp substrate 
rhodamine 123 (Rho). Briefly, cells were 
incubated with 0.5 µg/mL Rho in PBS for 30 min 
at 37˚C, washed in PBS and incubated in medium 
at 37˚C for the time points indicated in the figure 
legend. The kinetic of rhodamine retention was 
quantified by flow cytometry. 
Western blot analysis.  Cell lysates for 
immunoblots were prepared by sonicating cells at 
107/ml in 50 mM Tris-HCl (pH 6.8), 10% glycerol, 
2% SDS, 5 mM DTT, 0.5 mM 
phenylmethylsulfonylfluoride and complete 
protease inhibitor mixture (Calbiochem). Samples 
corresponding to 40 µg proteins were mixed with 
SDS-PAGE loading buffer and incubated 10 min at 
room temperature to prevent P-gp aggregation. 
Samples were separated on 7.5% SDS-PAGE gels, 
transferred to nitrocellulose membranes, and 
probed using anti-P-gp C219 (1: 50), and anti-
tubulin (1:2000) monoclonal antibodies. 
Immunoreactive bands were visualized with 
horseradish peroxidase-conjugated secondary 
antibodies and enhanced chemiluminescence 
(ECL). 
Determination of protein concentration. Protein 
content was determined using the Bio-Rad Protein 
Assay according to the instructions provided by the 
manufacturer. Bovine serum albumin was used for 
the standard curve. 
Statistical analyses. Data are expressed as means ± 
SE. 1-way analysis of variance (ANOVA) was 
performed (GraphPad Prism 4.0c, GraphPad 
Software, Inc.) and a probability value < 0.05 
was considered statistically significant. When 
the overall probability value was < 0.05, the 
Dunnett multiple-comparisons test was used as 
a posttest to determine if there was a 
significant difference between values of 
control (reference sample) and samples of 
interest. 
 
RESULTS 
 
Host cell P-gp is essential for normal parasite 
replication. To determine whether the activity of 
host P-gp plays a role in parasite replication, host 
cells expressing different levels of the protein (fig. 
S1) were infected with T. gondii expressing β-
galactosidase, which allows parasite quantification 
by colorimetric reaction (21). Direct parasite count 
at 24 hrs post-infection (p.i.) revealed the presence 
of smaller vacuoles containing fewer parasites in 
P-gp deficient host cells (fig. 1A). Importantly, 
complementation of P-gp deficient cells with the 
human P-gp homologue fully restored parasite 
replication. Analysis of parasite burden by 
visualization of parasite vacuoles at 48 hrs p.i. (fig. 
1B) and colorimetric reaction at 48 and 72 hrs p.i. 
(fig. 1C) confirmed that T. gondii replication was 
strongly inhibited in the absence of host P-gp. In 
addition, P-gp complemented host cells generated 
a higher T. gondii burden than that found in WT 
cells. To further confirm that P-gp activity confers 
a replication advantage for the parasite, we used 
WT 3T3 fibroblasts transfected to overexpress P-
gp as host cells (12). Parasite quantification was 
performed either at the level of single host cells 
using flow cytometry (fig. S2A) or as parasite 
burden of the whole host cell monolayer by 
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colorimetric reaction (fig. S2B). Both analyses 
indicated a positive correlation between P-gp 
expression levels and parasite replication. Absence 
of the multidrug transporter MRP1, in addition to 
the two P-gp isoforms (triple KO cells) (11), did 
not further decrease parasite replication (data not 
shown). Collectively, these data unambiguously 
show that the presence of an active P-gp in the host 
is directly involved in a process controlling T. 
gondii replication. 
Host cell P-gp is not involved in parasite 
invasion. The reduction in parasite number seen in 
P-gp deficient cells could have resulted from either 
decreased parasite replication or decreased 
invasion efficiency. In order to assess whether the 
absence of P-gp on the host plasma membrane 
compromises the ability of T. gondii to enter host 
cells, an invasion assay was performed using 
parasites harvested from WT host cells and 
allowed to infect cells expressing different levels 
of P-gp. The number of intracellular parasites was 
comparable in host cells expressing basal P-gp 
levels, P-gp deficient and P-gp complemented at 2 
hrs  post infection (fig. 1D), indicating that host P-
gp is not required for parasite invasion and that the 
reduced parasite burden observed in DKO cells is 
not due to a defect in host cell entry. 
Host cell P-gp deficiency inhibits cholesterol 
transport to T. gondii. The reduced parasite 
replication observed in P-gp deficient host cells led 
us to hypothesize that the absence of P-gp may 
disturb the supply of lipid components necessary 
for assembly of new parasite membranes. To test 
this hypothesis, we evaluated cholesterol 
trafficking and metabolism in the parasite, as T. 
gondii is auxotrophic for cholesterol and depends 
solely on the host for its supply (22). When we 
tested the transport of exogenous radiolabeled 
cholesterol to the parasite, we found that in the 
absence of host P-gp cholesterol delivery was 
strongly reduced (fig. 2A). Importantly, P-gp DKO 
cells showed normal uptake of exogenous 
cholesterol (fig. S3), indicating that the reduced 
cholesterol transport to the parasite is not caused 
by a compromised uptake of this lipid by the host 
cells. In addition, the increased T. gondii 
replication in P-gp complemented host cells 
coincided with enhanced cholesterol delivery to 
the parasites, suggesting that the level of 
cholesterol transport was regulating parasite 
replication rate. 
In addition, we monitored the cholesterol transport 
in vivo by using the fluorescently labeled analogue 
NBD-cholesterol (fig. 2B). Similar to the 
observations during the radiolabeled cholesterol 
incubation, transport of NBD-cholesterol to 
parasites grown in DKO cells was reduced 
compared with WT cells and a pattern of 
punctuated structures, reminiscent of endocytic 
vesicles, accumulated around the parasite vacuoles. 
Conversely, parasites infecting P-gp 
complemented cells showed high level of 
fluorescence, indicating a robust trafficking of 
cholesterol to the vacuole. 
To test whether decreased cholesterol availability 
in absence of host P-gp was directly responsible 
for the reduced T. gondii replication, we evaluated 
the parasite burden in DKO cells loaded with 
exogenous cholesterol following infection. This 
treatment improved parasite replication in a dose 
dependent manner (fig. 2C), confirming that 
insufficient cholesterol availability was indeed the 
limiting factor for parasite replication.  
To investigate the mechanism of P-gp involvement 
in the cholesterol trafficking to T. gondii, we 
inhibited the vesicular transport of host cholesterol 
from lysosomes to both plasma membrane and 
endoplasmic reticulum with the class-2 amphiphile 
U-18666A (23). Treatment with U-18666A has 
been shown to decrease the cholesterol delivery to 
intracellular  parasites (22). This broad inhibition 
of cholesterol trafficking severely affected T. 
gondii replication in WT host cells, with higher 
levels of inhibition than the ones observed in P-gp 
defective cells (fig. 2D). On the other hand, 
parasite replication in DKO cells was further 
inhibited by only 10% upon U-18666A treatment. 
The absence of a significant cumulative effect 
between lack of P-gp and inhibitor treatment 
indicates that P-gp may operate, directly or 
indirectly, on a similar pathway of cholesterol 
trafficking that is essential for parasite replication. 
P-gp associates with the parasite vacuole. Our 
previous results suggest that P-gp may be involved 
in the cholesterol trafficking to the parasite via the 
endocytic pathway. To investigate this possibility 
we localized host P-gp in infected cells. P-gp is 
mainly present in the plasma membrane of the 
cells, but a minority also localizes in intracellular 
compartments, including endo-lysosomes (24,25). 
As endo-lysosomes have been shown to be 
recruited to the PV in T. gondii infected cells (8), 
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we reasoned that P-gp also associates with the 
parasite vacuole. To test this hypothesis, we 
infected P-gp complemented host cells, whose 
level of P-gp expression allows analysis by 
immunofluorescence using the P-gp specific 
monoclonal antibody C219 (fig. S1A). This 
analysis showed that P-gp was predominantly 
present on the host plasma membrane as expected. 
In addition, P-gp was also found closely associated 
with the PV (fig. 3A, B). 
Host organelles are recruited to the PV in 
absence of host P-gp. T. gondii scavenges 
cholesterol from host endo-lysosomal 
compartments (22), and these organelles are 
actively recruited by the parasite to the PV in a 
time dependent manner after infection (8). To test 
whether the decreased cholesterol delivery to the 
parasite in P-gp deficient cells was due to a failure 
in recruiting the cholesterol rich endo-lysosomes, 
we probed the localization of these organelles in 
infected cells (fig. 3C). First we analyzed the 
labeling of endocytic vesicles using cholera toxin 
B-subunit (CTX), which binds to the raft-
associated sphingolipid GM1 and enters the cell by 
retrograde transport in the secretory pathway (26). 
CTX positive structures were equally found around 
the PV of parasites infecting WT, DKO and P-gp 
complemented host cells. Moreover, Lamp1 
(Lysosome-associated membrane protein 1) 
staining further confirmed that lysosomes are 
recruited to the PV in DKO cells. Finally, host 
Golgi, which was previously shown to redistribute 
at the PV (8), was also found close to the PV 
surface in all tested cell lines. Collectively, our 
results show that the absence of host P-gp does not 
inhibit the parasite-mediated recruitment of host 
organelles to the PV. 
Cholesterol accumulates outside the PV in 
absence of host P-gp.  Despite the normal 
recruitment of lysosomes around the PV in DKO 
host cells, the accumulation of NBD-cholesterol 
observed in this cell type (fig.2B) prompted us to 
analyze whether the intracellular distribution of 
endogenous cholesterol is altered in absence of 
host P-gp. Staining of unesterified cholesterol with 
the poliene antibiotic filipin (27) in infected WT 
cells showed labeling of parasite membranes and 
perinuclear vesicular structures, previously 
reported to be endo-lysosomal compartments (fig. 
4A). On the contrary, in DKO cells the filipin-
positive vesicular structures were bigger and more 
intensely labeled and accumulated outside the PV. 
Importantly, P-gp complementation prevented the 
cholesterol accumulation, indicating that the 
cholesterol accumulation is P-gp dependent. 
Inhibition of cholesterol transport to the parasite 
vacuole does not depend on H.O.S.T. formation.  
Next we assessed whether the defective transport 
of cholesterol to the parasite resulted from a faulty 
formation of the H.O.S.T. system, a recently 
described structure that can supply the parasite 
with cholesterol contained in host endo-lysosomes 
(8). Analysis by electron microscopy found normal 
recruitment of host organelles to the PV, including 
mitochondria, both in WT and DKO host cells (fig. 
4B, arrowheads). Importantly, parasites grown in 
DKO host cells were able to form H.O.S.T. 
structures with clearly visible tubules and vesicles 
(fig. 4B, arrows and magnified images). Thus, host 
P-gp is not required for the formation of 
structurally normal parasite vacuoles. In this 
respect, the observed inhibition of cholesterol 
transport despite the formation of H.O.S.T. 
suggests that either P-gp acts at a later stage than 
the development of these structures, or it affects a 
H.O.S.T. independent mechanism of cholesterol 
delivery. To test the latter hypothesis, we analyzed 
the replication of Neospora caninum, an 
apicomplexan parasite related to T. gondii whose 
intracellular vacuoles recruits host endo-lysosomes 
(fig. S4), but are devoid of H.O.S.T. (8).  As with 
T. gondii, N. caninum replication was inhibited in 
absence of host P-gp, and could be rescued by P-
gp complementation (fig. 4C). In addition, N. 
caninum growth in DKO host cells resulted in 
decreased free cholesterol content and cholesteryl 
ester storage in lipid droplets (fig. 4D), suggesting 
that P-gp mediated cholesterol supply to the 
parasite operates via a mechanism independent of 
the H.O.S.T. system found in the PV. 
Host cell P-gp deficiency affects T. gondii 
sphingolipid metabolism. Our previous results 
showed that cholesterol transport to the parasite is 
defective in P-gp deficient host cells. We then 
investigated whether this impaired transport 
affected the parasite’s lipid content. Lipid analyses 
of T. gondii maintained in DKO host cells revealed 
that the steady state of cholesterol content was 
comparable to WT after one lysis passage (23 ± 1.6 
µg/mg protein) but decreased after prolonged 
growth in these cells (four lysis passages) (fig. 
5A). Similar to the observations in N. caninum, a 
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marked decrease in cholesteryl esters stored in 
lipid droplets was observed in parasites isolated 
from DKO cells (fig. S5). 
Since cholesterol is an important regulator of 
membrane fluidity, membrane domains and 
signaling processes (rev. in (28)), we investigated 
whether the reduced cholesterol content observed 
in T. gondii grown in DKO host cells affected the 
lipid profile of the parasite’s membranes. 
Unexpectedly, liquid chromatography-mass 
spectrometry (LC-MS) analysis of parasite 
sphingolipids revealed a considerably higher 
amount of ceramide, ceramide 
phosphatidylethanolamine, sphingomyelin and 
lactosylceramide, while the levels of 
glucosylceramide did not change (fig. 5B). Given 
the crucial role of ceramide in cell physiology both 
as a precursor of complex sphingolipids and as a 
second messenger regulating a variety of cellular 
processes (rev. in (29)), we analyzed whether 
neosynthesis of this lipid was up-regulated in T. 
gondii grown in DKO host cells. Metabolic 
labeling of extracellular parasites revealed that  
ceramide synthesis was higher in T. gondii isolated 
from DKO host cells after four lysis passages than 
in WT cells (fig. 5C), supporting the hypothesis 
that the higher ceramide levels observed are indeed 
an active response of the parasite. These results 
suggest that reduced cholesterol availability 
triggers compensatory mechanisms in T. gondii, 
presumably to adapt to the intracellular 
environment of DKO cells and/or to adjust the 
lipid composition of its membranes. 
Absence of P-gp alters normal cholesterol 
metabolism in uninfected fibroblasts. The 
observed inhibition of cholesterol transport to the 
parasite and the accumulation of cholesterol-
loaded organelles around the PV in P-gp deficient 
host cells prompted us to analyze whether P-gp is 
also involved in cholesterol trafficking in 
uninfected host cells. To test this hypothesis, we 
investigated whether P-gp expression levels 
correlated with alterations in cholesterol 
metabolism in fibroblasts. Analysis of intracellular 
cholesterol distribution visualized with filipin 
revealed that P-gp DKO cells accumulated 
cholesterol in perinuclear vesicles compared with 
WT and P-gp complemented cells (fig. 6A). In 
addition, despite comparable uptake of 
radiolabeled cholesterol (fig. S3), DKO cells 
showed a time dependent increase in cholesterol 
esterification compared with WT cells (fig. 6B). 
On the other hand, P-gp complementation of DKO 
cells lowered the levels of cholesterol 
esterification. This correlation between the absence 
of P-gp and increased cholesterol esterification 
was evident not only in the kinetics of the process, 
but also in the steady state cholesteryl ester content 
(fig. S6). Next we evaluated cholesterol levels in 
the plasma membrane by extraction with methyl-β-
cyclodextrin (CD) or efflux to the extracellular 
acceptors reconstituted HDL (30) and 
apolipoprotein A-I (apoA-1). We found that less 
cholesterol could be extracted with CD from the 
plasma membrane of DKO cells and that P-gp 
complementation increased the level of cholesterol 
extraction (fig. 6C). Furthermore, P-gp 
complementation also enhanced the ABCA1-
mediated efflux of cholesterol to its natural 
acceptor HDL (fig. 6D), and apoA-1 (fig. 6E). 
These data reveal that cells deficient in P-gp 
accumulated free and esterified cholesterol in 
perinuclear vesicular structures and cytosolic lipid 
droplets respectively. On the other hand, cells 
expressing high levels of P-gp showed increased 
amounts of cholesterol in the plasma membrane 
which then resulted in increased efflux to 
extracellular acceptors. To further test whether WT 
cells were more prone to accumulate free 
cholesterol in the plasma membrane than DKO 
cells, we exploited the toxicity induced by 
destabilizing the plasma membrane via exogenous 
cholesterol loading. Analysis of cell viability 
showed that DKO cells were minimally affected by 
exogenous cholesterol loading, whereas viability 
decreased with increasing levels of P-gp 
expression in WT and P-gp complemented cells 
(fig. 6F). As previously reported in cholesterol-
loaded macrophages (31), blocking cholesterol 
transport from lysosomes to the plasma membrane 
using the hydrophobic amine U-18666A (23) 
prevented the cholesterol toxicity in P-gp 
expressing cells, but did not alter the viability of 
DKO cells (data not shown). Thus, these data 
suggest that inhibition of intracellular cholesterol 
transport mimics the increased survival of DKO 
cells during cholesterol loading.  
 
DISCUSSION 
 
P-gp is a unique transporter due to its broad 
substrate specificity and its expression constitutes 
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a major obstacle in the fight against multidrug-
resistant tumor cells and pathogens. Yet P-gp also 
plays a key role in normal physiological processes, 
including preventing cellular toxicity at the blood 
brain barrier, as shown in vivo by the extremely 
high sensitivity of P-gp KO mice to toxic 
compounds (32). 
Our aim was to investigate whether host P-gp 
plays a role in host-pathogen interaction that is 
distinct from multidrug resistance. Previous studies 
using P-gp inhibitors suggested that T. gondii may 
require a functional P-gp to survive in the host cell 
(33). In the present work more detailed 
investigation found that host P-gp is in fact a 
crucial modulator of T. gondii and N. caninum 
replication. In addition, we found that host P-gp is 
not a receptor for the parasite and its absence does 
not affect parasite invasion or the formation of 
structurally normal parasite vacuoles. Importantly, 
we found that transport of cholesterol from the 
host cell to the parasites, a process on which T. 
gondii is completely dependent, was impaired in 
absence of host P-gp. Biochemical analyses 
revealed that the parasite’s lipid composition was 
altered when grown in P-gp deficient host cells. 
Specifically, both free and esterified cholesterol 
levels were reduced, as expected from a decreased 
uptake of cholesterol from the host; interestingly, 
the content of selected sphingolipids also changed 
compared with T. gondii grown in WT cells. In 
particular, the level of sphingomyelin, a major 
structural sphingolipid mainly found on the plasma 
membrane, was increased two fold. Sphingomyelin 
has a high affinity for and closely associates with 
cholesterol and both lipids contribute to the 
ordered state of plasma membrane domains. While 
it is well accepted that cholesterol homeostasis is 
modulated by sphingomyelin content, studies on 
the regulation of sphingomyelin metabolism by 
varying the cellular cholesterol levels produced 
contradictory results in different cell types 
analyzed (rev. in (34)). However, cholesterol 
depletion was shown to stimulate sphingomyelin 
synthesis in fibroblasts (35), and high levels of 
sphingolipids can retain the ordered  state of model 
membranes (36), suggesting that in conditions of 
cholesterol depletion, increased sphingomyelin 
content could still contribute to the maintenance of 
an ordered plasma membrane structure. Thus it is 
possible that the increased sphingomyelin content 
detected in parasites with limited cholesterol levels 
plays a role in conserving the structural properties 
of parasite membranes. 
Also noteworthy was the increased ceramide 
content in parasites from P-gp deficient host cells. 
It is tempting to speculate that this elevation is a 
compensatory mechanism for the decreased 
cholesterol in the membranes, as ceramide-
cholesterol replacement has been shown to occur 
in vitro (37). However, the ceramide increase 
observed does not justify this hypothesis, as 
similarly for mammalian cells, ceramide in the 
parasite is about 10 times less abundant than 
cholesterol. On the other hand, ceramide plays a 
well known role of second messenger in a variety 
of cellular processes, including stress response 
(rev. in (38)), thus it seems more likely that the 
enlarged ceramide pool helps to fulfill the 
signaling needs of T. gondii in a host cell 
environment not optimal for parasite survival. The 
increased ceramide synthesis observed in labeled 
parasites isolated from P-gp deficient host cells 
supports the idea that the content of this lipid is 
modulated at least in part by an active synthetic 
process in the parasite. Scavenging of 
sphingolipids from the host cell can not be 
excluded at this stage, although it has not been 
demonstrated to date in this parasite. 
While our results clearly indicate that cholesterol 
transport from the host to the parasite is defective 
in absence of host P-gp, the data regarding the 
modality of this transport were quite surprising. So 
far, T. gondii has been shown to depend on two 
forms of host-derived cholesterol: free cholesterol 
contained in endo-lysosomes (22) and esterified 
cholesterol, present in cytosolic lipid bodies (14). 
The former requires functional host vesicular 
trafficking (22,39) and relies on the recruitment of 
host endo-lysosomes around the PV and their 
diversion to the PV interior via the formation of  
H.O.S.T. structures (8). Our data show that P-gp 
deficient cells were competent for both cholesterol 
esterification, endo-lysosome recruitment to the 
PV and H.O.S.T. formation, thus the inhibition of 
cholesterol trafficking to the parasite cannot be 
attributed to lack of these processes. However, the 
observed accumulation of cholesterol in endo-
lysosomes in P-gp deficient cells raised the 
possibility that P-gp contributes to the cholesterol 
mobilization from lysosomes to the PV, a crucial 
process for cholesterol trafficking to the PV (8,22). 
Thus, P-gp in endocytic compartments (25) could 
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help to mobilize cholesterol from endo-lysosomes 
either juxtaposed to or internalized in the PV via 
the H.O.S.T. system. This scenario is also in 
agreement with the reduced cholesterol content in 
N. caninum when grown in P-gp deficient cells, as 
the PV of this parasite does not contain H.O.S.T., 
but is in close proximity with host endo-
lysosomes. 
Collectively, these results show that host P-gp 
plays an important role in cholesterol transport to 
the parasite vacuole. However, there are several 
observations which imply that P-gp does not 
control all cholesterol transport to the parasite and 
that P-gp independent transport pathways must 
also exist, namely (i) the slight (10%) additional 
inhibition of parasite replication in DKO cells 
following U-18666A drug treatment, (ii) the 
increased parasite replication upon cholesterol 
loading of DKO cells, and (iii) the parasite’s 
ability to replicate in DKO cells for several lysis 
passages.  
Considering these results, it seems that the 
mechanism underlying P-gp mediated cholesterol 
transport to the parasite is most likely to fall within 
one of two general scenarios, namely (i) P-gp does 
not transport cholesterol directly, but is critical in 
another yet unidentified cellular process essential 
for cholesterol transport and parasite replication, or 
(ii) P-gp plays a direct, but seemingly not 
exclusive, role in cholesterol transport and/or 
metabolism. The role of P-gp as a transporter of 
cellular cholesterol has been the subject of 
considerable debate. While the presence of 
cholesterol in the membrane surrounding P-gp is 
crucial for the ATPase activity of the protein (40), 
results of studies addressing P-gp’s role in 
cholesterol trafficking have been contradictory. P-
gp has been proposed to translocate cholesterol 
between the plasma membrane leaflets in vitro 
(40). In addition, several reports using chemically 
selected cell lines or inhibitors associated P-gp 
over-expression with increased cholesterol 
transport to the endoplasmic reticulum and 
consequent esterification (rev. in (41)). However, 
from these studies it is not clear whether the 
enhanced cholesterol trafficking observed is due to 
a direct role of the protein or to an elevated 
turnover of the cholesterol-rich membranes where 
P-gp is located (42). Our understanding of P-gp 
mediated cholesterol transport is further 
compromised by the contradictory results obtained 
through the use of P-gp inhibitors with potential 
side-effects and cell type-specific outcome of P-gp 
expression (41). In our work using P-gp deficient 
cells we found that free cholesterol accumulated in 
vesicular structures located in the perinuclear 
region and that this accumulation was absent once 
P-gp activity was restored. In addition, contrary to 
previous reports using P-gp inhibitors (43,44) or 
selected MDR cell lines (45), cholesteryl esters 
accumulated in absence of P-gp. Interestingly, a 
similar increase in cholesterol esterification was 
observed in vivo in the liver of P-gp deficient mice 
(46). Furthermore, we found a positive correlation 
between cholesterol extractability/efflux from the 
plasma membrane and P-gp expression. Taken 
together, our results suggest that P-gp does play a 
significant role in cholesterol transport in both 
host-parasite interaction and in normal metabolism 
of fibroblasts. 
Thus, although an indirect effect on cholesterol 
transport in the absence of P-gp cannot be 
completely excluded, we observed a number of 
indications consistent with a model in which P-gp 
resident in the endo-lysosomes is involved in 
cholesterol mobilization from these compartments 
to the PV in case of parasite infection. These 
indications include: the endo-lysosome recruitment 
around the PV in infected cells, the cholesterol 
accumulation outside the PV and the reduced 
cholesterol supply to the parasite in the absence of 
host P-gp, and the observation that P-gp mediated 
parasite inhibition depends on vesicular trafficking 
of cholesterol. In addition, several alterations in 
cholesterol metabolism observed in DKO host 
cells also suggest that P-gp plays a role in 
cholesterol trafficking from endo-lysosomes to the 
plasma membrane in uninfected cells. Such 
observations include the accumulation of free 
cholesterol in endo-lysosome like structures in the 
absence of P-gp, the decreased recycling of 
exogenous cholesterol to the plasma membrane 
and the increase in cholesterol esterification. On 
the other hand, increased P-gp expression in host 
cells correlates with increased cholesterol content 
in the plasma membrane and efflux, and increased 
sensitivity to cholesterol loading toxicity.  
In summary, our studies using the intracellular 
parasites T. gondii and N. caninum provide 
evidence that host cell P-gp plays a previously 
unidentified role in host-parasite interaction. Our 
results reveal that host P-gp is required for 
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cholesterol transport to the parasite vacuole via a 
mechanism independent of H.O.S.T. formation, 
and is also involved in normal cholesterol 
metabolism in uninfected mammalian fibroblasts. 
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FIGURE LEGENDS 
 
Fig. 1: Host cell P-gp modulates parasite replication. A. WT, P-gp deficient (DKO) and P-gp 
complemented (DKO/P-gp) host cells were infected with T. gondii at multiplicity of infection (MOI) 1. 
After 24 hrs post infection (p.i.), intracellular parasites were quantified by direct counting. The 
distribution of the parasite number in single vacuoles is expressed as percentage of total vacuoles 
examined (n>30). B. Immunofluorescence analysis of intracellular vacuoles containing parasites at 
48 hrs p.i. using anti-T. gondii serum, followed by fluorescein-conjugated secondary antibodies. 
C. Quantification of parasite burden at 48 and 72 hrs p.i. by a colorimetric assay measuring the amount 
of parasite-expressed β-galactosidase. Results are expressed as percentage of parasite number in WT host 
cells ± standard error (SE) (n=6). *p < 0.05 and **p < 0.01. D. Host cell monolayers were incubated with 
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung on August 11, 2009 
w
w
w
.jbc.org
D
ow
nloaded from
 
 12
T. gondii at MOI 1. After 2 hrs incubation, 20 fields of infected cells were examined and the number of 
intracellular invaded parasites determined as described in the material and methods section. Data are 
expressed as percentage of total parasite number ± SE (n=20).  
 
Fig. 2: Host cell P-gp deficiency inhibits cholesterol transport to T. gondii. A. T. gondii-infected host cells 
were labeled for 5 hrs with 0.5 µCi/mL [3H]cholesterol. Parasites were isolated and [3H]cholesterol 
incorporation measured by liquid scintillation. Data are expressed as percentage of cholesterol in parasites 
(dpm/106 parasites) isolated from WT host cells ± SE (n=6). B. Host cell monolayers were infected with 
T. gondii for 24 hrs followed by incubation with NBD-cholesterol and observed by fluorescence 
microscopy. Asterisks indicate parasite vacuoles. C. After T. gondii invasion, DKO host cells were loaded 
with the indicated concentrations of cyclodextrin-cholesterol complexes and parasite replication 
monitored at 48 hrs p.i. as described in Fig. 1. Data are average ± SE (n=3). D. After T. gondii infection, 
WT and DKO host cells were treated with the class-2 amphiphile U-18666A at the indicated 
concentrations and parasite replication quantified at 48 hrs p.i. Results are expressed as percentage of 
parasite number in untreated (cntl) WT cells. Data are average ± SE (n=6). 
 
Fig. 3: Host P-gp associates with the parasite vacuole. A. Confocal microscopy of P-gp localization in P-
gp complemented (DKO/Pgp) cells infected for 24 hrs with T. gondii. Nuclear DNA was stained with 
DAPI. PV, parasitophorous vacuole. DIC, differential interference contrast image. B. Confocal 
microscopy of infected cells as described in panel A, showing P-gp (green) and parasite (red) staining. C. 
Fluorescence microscopy of infected WT, P-gp deficient (DKO) and P-gp complemented (DKO/P-gp) 
host cells showing that T. gondii PV associated with labeled host endo-lysosomes (cholera toxin (CTX)), 
lysosomes (Lamp1) and Golgi (giantin). Asterisks indicate parasite vacuoles. 
 
Fig. 4: Cholesterol accumulates outside the parasite vacuole in absence of host P-gp. A. WT, P-gp 
deficient (DKO) and P-gp complemented (DKO/P-gp) host cell monolayers were infected with T. gondii 
for 24 hrs. After fixation, the intracellular distribution of unesterified cholesterol was visualized with 
filipin and observed by fluorescence microscopy. Arrows indicate parasite vacuoles. B. Electron 
microscopy of T. gondii infected WT and P-gp deficient (DKO) host cells at 24 hrs p.i., showing PV-
associated mitochondria (arrowheads) and H.O.S.T. structures (arrows). Right, magnification of H.O.S.T. 
structures. Scale bars, 2 µm. C. Host cells monolayers were infected with N. caninum and parasite 
replication quantified at 72 hrs p.i., as described. Results are expressed as percentage of parasite number 
in WT host cells ± SE (n=3). D.  Lipids were extracted from N. caninum isolated from WT or DKO host 
cells after 4 lysis passages. A representative TLC of lipids corresponding to equal protein amount is 
shown. Free cholesterol (FC) and cholesteryl esters (CE) were visualized with CuSO4. Inset, Nile red 
staining of cholesteryl esters-containing lipid droplets in parasites isolated from WT or DKO host cells 
after 4 lysis passages. 
 
Fig. 5: Host cell P-gp deficiency affects T. gondii lipid metabolism. A. Quantification of free cholesterol 
(FC) and cholesteryl esters (CE) by enzymatic reaction (Amplex red®) in T. gondii isolated from WT or 
DKO host cells after 4 lysis passages. Data are expressed as percentage of lipid content in T. gondii from 
WT cells ± SE (n=5). B. LC-MS analysis of sphingolipids of T. gondii isolated from WT or DKO host 
cells after 4 lysis passages. Data are average ± SE (n=3) of a representative from two experiments done in 
triplicate. Cer, ceramide; GlcCer, glucosylceramide; LacCer, lactosylceramide; CerPE, ceramide 
phosphoethanolamine. The predominantly detected C16 species are plotted. SM, sphingomyelin. C. Left, 
TLC separation of de novo synthesized lipids labeled with [3H]palmitic acid in T. gondii isolated from WT 
(1) or DKO (2) cells. Right, newly synthesized ceramide is expressed as percentage of ceramide in T. 
gondii isolated from WT host cells. Data are average ± SE (n=3). 
 
Fig. 6: P-gp expression alters cholesterol metabolism in fibroblasts. A. Filipin labeling of WT, P-gp 
deficient (DKO) and P-gp complemented (DKO/P-gp) host cells monolayers to visualize the intracellular 
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distribution of unesterified cholesterol. B. Host cells were labeled with [3H]cholesterol and the time course 
of [3H]cholesterol esterification measured at the indicated time points. Data are percentage of 
[3H]cholesteryl esters (CE) of total cellular [3H]cholesterol. C. Cells were labeled with [3H]cholesterol for 
24 hrs, washed and incubated with 2 mM methyl-β-cyclodextrin. Medium aliquots were taken at the 
indicated time points and extracted [3H]cholesterol measured by liquid scintillation. Extracted cholesterol 
is expressed as percentage of total [3H]cholesterol (medium + cell associated radioactivity). Cells were 
similarly labeled and incubated with 20 µg/mL reconstituted HDL (D) or 10 µg/mL apolipoprotein A-I 
(E). Cholesterol efflux is expressed as percentage of total [3H]cholesterol as before. F. Cells were loaded 
with the indicated concentrations of cyclodextrin-cholesterol complexes for 24 hrs and viability measured 
by AlamarBlue® assay. Results are expressed as percentage of untreated (cntl) cell viability. All data are 
average ± SE (n=3). 
 
 
 
 
 
 
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung on August 11, 2009 
w
w
w
.jbc.org
D
ow
nloaded from
 
 14
Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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